•  
  •  
  •  
  •  

2025-11-30 09:01:39

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Cantabil Retail India Ltd opens 3 new shops in November 2025
  • Advait Energy Transitions Ltd receives order from Malaysia
  • SRM Contractors Ltd receives ET Infra Leadership Award 2025
  • Ceinsys Tech Ltd receives additional order from MRSAC
  • Apeejay Surrendra Park Hotels Ltd inks MoU for 42 room hotel in Mathura

Keywords Selected:  Laboratories

Research

  • Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY
  • BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

IPO News

  • Ambey Laboratories Ltd IPO to open for subscription on July 4, 2024
  • Valiant Laboratories Ltd to raise funds through IPO

Stock Report

  • Astal Laboratories Ltd Secures LoI for 60 Tonnes of Piroctone Olamine from Swiss Distributor
  • Astal Laboratories Ltd receives REACH Compliance Certificate
  • Dr. Reddy's receives European Commission Approval for AVT03 (denosumab), a Proposed Biosimilar of Prolia® and Xgeva®
  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Ind-Swift Laboratories Ltd receives certifications from Bureau Veritas
  • Alkem launches probiotic 'DSS', the original De Simone formulation, in India for gut health management
  • Caplin Point Laboratories Ltd's arm acquires land in Mexico
  • USFDA inspects Unit 1 of Divi's Laboratories Limited
  • SPARC announces consolidation of R&D laboratories and facilities
  • Valiant Advanced Sciences Pvt Ltd commences commercial operations at its new state-of-the-art greenfield manufacturing facility in Saykha, Gujarat
  • Gujarat Terce Laboratories Ltd Q2FY26 PAT at Rs. 1.40 crore
  • Neuland Q2FY26 Total income at Rs.516.1 crore; EBITDA at Rs.156.9 crore
  • Caplin Point Laboratories Ltd consolidated Q2FY26 PAT up at Rs. 154.45 crores
  • Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immunotherapeutics and regenerative medicines
  • Colinz Laboratories Ltd Q2FY26 profit at Rs. 14.05 lakhs
  • Unichem Laboratories Ltd pays fine of Euro 16,753,873.41 to European Commission
  • Dr Reddys Laboratories Ltd reports Rs. 1437.2 crores consolidated PAT in Q2FY26
  • Caplin Steriles Ltd receives USFDA approval for ANDA Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection
  • Coral Laboratories Ltd announces capacity expansion of Ointment Manufacturing
  • Dr. Reddy's receives positive CHMP opinion from European Medicines Agency for AVT03 - denosumab
  • Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
  • Emerald Finance Ltd partners with Ind-Swift Laboratories Ltd for Early Wage Access program
  • Dr. Reddy's launches novel molecule 'Tegoprazan' in India
  • Caplin Steriles Ltd granted final approval for ANDA Milrinone Lactate in 5% Dextrose Injection by USFDA

Industry News

  • Hamdard invests in SIG's aseptic carton technology to meet diverse consumer demands

Latest Post

  • Cantabil Retail India Ltd opens 3 new shops in November 2025
  • Advait Energy Transitions Ltd receives order from Malaysia
  • SRM Contractors Ltd receives ET Infra Leadership Award 2025
  • Ceinsys Tech Ltd receives additional order from MRSAC
  • Apeejay Surrendra Park Hotels Ltd inks MoU for 42 room hotel in Mathura


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024